| The Nordic prescription databases as a resource for pharmacoepidemiological research—a literature review B Wettermark, H Zoëga, K Furu, M Korhonen, J Hallas, M Nørgaard, ... Pharmacoepidemiology and drug safety 22 (7), 691-699, 2013 | 210 | 2013 |
| Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance B Godman, B Wettermark, M Hoffmann, K Andersson, A Haycox, ... Expert review of pharmacoeconomics & outcomes research 9 (1), 65-83, 2009 | 186 | 2009 |
| Impact of a generic substitution reform on patients’ and society's expenditure for pharmaceuticals K Andersson, G Bergström, MG Petzold, A Carlsten Health Policy 81 (2-3), 376-384, 2007 | 123 | 2007 |
| What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden K Andersson, C Sonesson, M Petzold, A Carlsten, K Lönnroth Pharmacoepidemiology and drug safety 14 (5), 341-348, 2005 | 121 | 2005 |
| Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe B Wettermark, B Godman, K Andersson, LL Gustafsson, A Haycox, ... Pharmacoeconomics 26, 537-550, 2008 | 109 | 2008 |
| Prevalence, nature and potential preventability of adverse drug events–a population‐based medical record study of 4970 adults KM Hakkarainen, H Gyllensten, AK Jönsson, K Andersson Sundell, ... British journal of clinical pharmacology 78 (1), 170-183, 2014 | 105 | 2014 |
| Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures?: Interrupted time series analysis of cost, volume and cost per volume trends in Sweden … K Andersson, MG Petzold, C Sonesson, K Lönnroth, A Carlsten Health policy 79 (2-3), 231-243, 2006 | 98 | 2006 |
| Methods for assessing the preventability of adverse drug events: a systematic review KM Hakkarainen, KA Sundell, M Petzold, S Hägg Drug safety 35, 105-126, 2012 | 84 | 2012 |
| A comparative analysis of remuneration models for pharmaceutical professional services C Bernsten, K Andersson, Y Gariepy, S Simoens Health policy 95 (1), 1-9, 2010 | 80 | 2010 |
| Adherence to antihypertensive therapy and elevated blood pressure: should we consider the use of multiple medications? K Hedna, KM Hakkarainen, H Gyllensten, AK Jönsson, ... PloS one 10 (9), e0137451, 2015 | 73 | 2015 |
| Cost of illness of patient-reported adverse drug events: a population-based cross-sectional survey H Gyllensten, C Rehnberg, AK Jönsson, M Petzold, A Carlsten, ... BMJ open 3 (6), e002574, 2013 | 73 | 2013 |
| Beliefs about medicines are strongly associated with medicine‐use patterns among the general population K Andersson Sundell, AK Jönsson International journal of clinical practice 70 (3), 277-285, 2016 | 71 | 2016 |
| Prevalence and perceived preventability of self-reported adverse drug events–a population-based survey of 7099 adults KM Hakkarainen, K Andersson Sundell, M Petzold, S Hägg PLoS One 8 (9), e73166, 2013 | 64 | 2013 |
| Influence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years KA Andersson, MG Petzold, P Allebeck, A Carlsten BMC health services research 8, 1-9, 2008 | 55 | 2008 |
| Beliefs about medicines among Swedish pharmacy employees TM Jörgensen, KA Andersson, ACM Mårdby Pharmacy World and Science 28, 233-238, 2006 | 49 | 2006 |
| Socioeconomic determinants of psychotropic drug utilisation among elderly: a national population-based cross-sectional study E Lesén, K Andersson, M Petzold, A Carlsten BMC Public Health 10, 1-9, 2010 | 46 | 2010 |
| Trust, reciprocity and collective action to fight antibiotic resistance. An experimental approach B Rönnerstrand, KA Sundell Social science & medicine 142, 249-255, 2015 | 43 | 2015 |
| A comparison of two methods for estimating refill adherence to statins in Sweden: the RARE project E Lesén, TZ Sandström, A Carlsten, AK Jönsson, AC Mårdby, KA Sundell Pharmacoepidemiology and drug safety 20 (10), 1073-1079, 2011 | 41 | 2011 |
| Glucose‐lowering treatment and clinical results in 163 121 patients with type 2 diabetes: an observational study from the Swedish national diabetes register N Ekström, M Miftaraj, AM Svensson, K Andersson Sundell, J Cederholm, ... Diabetes, Obesity and Metabolism 14 (8), 717-726, 2012 | 40 | 2012 |
| Consumer preferences for over-the-counter drug retailers in the reregulated Swedish pharmacy market H Håkonsen, KA Sundell, J Martinsson, T Hedenrud Health Policy 120 (3), 327-333, 2016 | 39 | 2016 |
